Seasickness Clinical Trial
Official title:
Meclizine Plasma Levels in Responders and Non-responders
Motion sickness is a debilitating condition that can effect many crew members. Meclizine has long been known as an effective anti motion sickness drug. The response to the drug is variable - some are responders, while others are resistant to the drug. The aim of the present study is to examine whether there is a correlation between meclizine plasma levels and clinical response.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05640258 -
Seasickness Susceptability and Vestibular Time Constant
|
N/A | |
| Completed |
NCT05004818 -
Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness
|
N/A |